Azin Alizadeasl, Somaye Ahmadi*, Kamran Roudini, Ronak Ahmadi and Haniye Hajiali Fini
Volume3-Issue11
Dates: Received: 2022-11-04 | Accepted: 2022-11-19 | Published: 2022-11-28
Pages: 1397-1403
Abstract
Background: Cancer is the second leading cause of mortality after cardiovascular disease. The second common leading cause of mortality in cancer patients is thrombosis, vary from arterial or venous thromboembolism to disseminated intravascular coagulation.
Case Report: Herein, we present a 58 years old lady with breast cancer under treatment, who suffered multiple thrombotic complications of cancer and chemotherapy.
Conclusion: In cancer patients disseminated intravascular coagulation presents insidiously, most frequent as a systemic hemorrhagic syndrome, resulting difficult and late diagnosis. Therefore, despite treatment, in most cases results in decreased survival.
FullText HTML
FullText PDF
DOI: 10.37871/jbres1610
Certificate of Publication
Copyright
© 2022 Alizadeasl A, et al. Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Alizadeasl A, Ahmadi S, Roudini K, Ahmadi R, Fini HH. Cancer Patient was attacked by Thrombosis: Case Report. 2022 Nov 28; 3(11): 1397-1403. doi: 10.37871/jbres1610, Article ID: JBRES1610, Available at: https://www.jelsciences.com/articles/jbres1610.pdf
Subject area(s)
References
- Bohdan M, Kowalczys A, Mickiewicz A, Gruchała M, Lewicka E. Cancer Therapy-Related Cardiovascular Complications in Clinical Practice: Current Perspectives. J Clin Med. 2021 Apr 13;10(8):1647. doi: 10.3390/jcm10081647. PMID: 33924543; PMCID: PMC8069381.
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209- 249. doi: 10.3322/caac.21660.
- Vyskočil J, Petráková K, Jelínek P, Furdek M. Kardiovaskulární komplikace nádorů a jejich léčby [Cardiovascular complications of cancers and anti-cancer therapy]. Vnitr Lek. 2017 Spring;63(3):200-209. Czech. PMID: 28379023.
- Giza DE, Iliescu G, Hassan S, Marmagkiolis K, Iliescu C. Cancer as a Risk Factor for Cardiovascular Disease. Curr Oncol Rep. 2017 Jun;19(6):39. doi: 10.1007/s11912-017-0601-x. PMID: 28421481.
- Abdol Razak NB, Jones G, Bhandari M, Berndt MC, Metharom P. Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment. Cancers (Basel). 2018 Oct 11;10(10):380. doi: 10.3390/cancers10100380. PMID: 30314362; PMCID: PMC6209883.
- Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation. 2003 Jun 17;107(23 Suppl 1):I17-21. doi: 10.1161/01.CIR.0000078466.72504.AC. PMID: 12814981.
- Kyriazi V, Theodoulou E. Assessing the risk and prognosis of thrombotic complications in cancer patients. Arch Pathol Lab Med. 2013 Sep;137(9):1286-95. doi: 10.5858/arpa.2012-0490-RA. PMID: 23991742.
- Khorana AA. Cancer and thrombosis: implications of published guidelines for clinical practice. Ann Oncol. 2009 Oct;20(10):1619-30. doi: 10.1093/annonc/mdp068. Epub 2009 Jun 26. PMID: 19561038.
- Herrmann J. Vascular toxic effects of cancer therapies. Nat Rev Cardiol. 2020 Aug;17(8):503-522. doi: 10.1038/s41569-020-0347-2. Epub 2020 Mar 26. PMID: 32218531; PMCID: PMC8782612.
- Gobel BH. Disseminated intravascular coagulation. Semin Oncol Nurs. 1999 Aug;15(3):174-82. doi: 10.1016/s0749-2081(99)80005-9. PMID: 10461702.
- Svilaas T, Lefrandt JD, Gietema JA, Kamphuisen PW. Long-term arterial complications of chemotherapy in patients with cancer. Thromb Res. 2016 Apr;140 Suppl 1:S109-18. doi: 10.1016/S0049-3848(16)30109-8. PMID: 27067963.
- Daher IN, Yeh ET. Vascular complications of selected cancer therapies. Nat Clin Pract Cardiovasc Med. 2008 Dec;5(12):797-805. doi: 10.1038/ncpcardio1375. Epub 2008 Oct 14. PMID: 18852710.
- Campia U. Vascular effects of cancer treatments. Vasc Med. 2020 Jun;25(3):226-234. doi: 10.1177/1358863X20914978. PMID: 32539632.
- Yhim HY. Challenging issues in the management of cancer-associated venous thromboembolism. Blood Res 2022;57(S1):S44-S48. doi: 10.5045/br.2022.2022025.
- Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM. Risk of Arterial Thromboembolism in Patients With Cancer. J Am Coll Cardiol. 2017 Aug 22;70(8):926-938. doi: 10.1016/j.jacc.2017.06.047. PMID: 28818202; PMCID: PMC5667567.
- Pasquini E, Gianni L, Aitini E, Nicolini M, Fattori PP, Cavazzini G, Desiderio F, Monti F, Forghieri ME, Ravaioli A. Acute disseminated intravascular coagulation syndrome in cancer patients. Oncology. 1995 Nov-Dec;52(6):505-8. doi: 10.1159/000227520. PMID: 7478440.
- Bick RL, Arun B, Frenkel EP. Disseminated intravascular coagulation. clinical and pathophysiological mechanisms and manifestations. Haemostasis. 1999;29(2-3):111-34. doi: 10.1159/000022493. PMID: 10629392.
- Trinh HL, Nguyen VT, Mai NK, Tran BT, Pham QN. Successful chemotherapy management of disseminated intravascular coagulation presenting with metastatic clear cell renal carcinoma: a case report and review of the literature. J Med Case Reports.2020;14:52. doi: 10.1186/s13256-020-02369-x.
- Levi M. Disseminated intravascular coagulation in cancer patients. Best Pract Res Clin Haematol. 2009 Mar;22(1):129-36. doi: 10.1016/j.beha.2008.12.005. PMID: 19285279.
- Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost. 2001 Sep;86(3):828-33. PMID: 11583315.
- Sohal S, Thakur A, Zia A, Sous M, Trelles D. Disseminated Intravascular Coagulation and Malignancy: A Case Report and Literature Review. Case Rep Oncol Med. 2020 Jan 2;2020:9147105. doi: 10.1155/2020/9147105. PMID: 31976103; PMCID: PMC6959140.
- Papageorgiou C, Jourdi G, Adjambri E. Disseminated intravascular coagulation: an update on pathogenesis, diagnosis, and therapeutic strategies. Clinical and Applied Thrombosis/Hemostasis. 2018;24(9_suppl):8S-28S. doi: 10.1177/1076029618806424.
- Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol Infect Dis. 2010 Aug 13;2(3):e2010024. doi: 10.4084/MJHID.2010.024. PMID: 21415977; PMCID: PMC3033145.
- Iba T, Levy JH, Raj A, Warkentin TE. Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation. J Clin Med. 2019 May 22;8(5):728. doi: 10.3390/jcm8050728. PMID: 31121897; PMCID: PMC6572234.
